These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 871390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone.
    Smith AG, Shuster S, Thody AJ, Alvarez-Ude F, Kerr DN.
    Br Med J; 1976 Apr 10; 1(6014):874-6. PubMed ID: 769907
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH.
    Bertagna X, Donnadieu M, Idatte JM, Girard F.
    J Clin Endocrinol Metab; 1977 Dec 10; 45(6):1179-86. PubMed ID: 201658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
    Welbel L, Zalewski K.
    Psychiatr Pol; 1971 Dec 10; 5(1):49-54. PubMed ID: 5551991
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Noncompetitive enzyme immunoassay (hetero-two-site enzyme immunoassay) for gamma 2-melanocyte-stimulating hormone (gamma 2-MSH) and measurement of immunoreactive gamma 2-MSH in plasma of healthy subjects.
    Yogi Y, Hashida S, Ekman R, Setoguchi T, Ishikawa E.
    J Clin Lab Anal; 1995 Dec 10; 9(6):397-406. PubMed ID: 8587009
    [Abstract] [Full Text] [Related]

  • 12. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure.
    Smith AG, Shuster S, Comaish JS, Plummer NA, Thody AJ, Alvarez-Ude F, Kerr DN.
    Br Med J; 1975 Mar 22; 1(5959):658-9. PubMed ID: 1125653
    [Abstract] [Full Text] [Related]

  • 13. MSH activity in pituitary glands of rats treated with tranquilizing drugs.
    Kastin AJ, Schally AV.
    Endocrinology; 1966 Nov 22; 79(5):1018-20. PubMed ID: 5951274
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A standard-controlled clinical study with propericiazine in schizophrenic patients.
    Ananth JV, Ban TA.
    Psychopharmacol Bull; 1977 Jul 22; 13(3):19-20. PubMed ID: 18754
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.